Solesence, Inc. Common Stock (SLSN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Solesence, Inc. Common Stock (SLSN) has a cash flow conversion efficiency ratio of -0.146x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.51 Million) by net assets ($17.23 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Solesence, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Solesence, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Solesence, Inc. Common Stock for a breakdown of total debt and financial obligations.
Solesence, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Solesence, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Delta Djakarta Tbk
JK:DLTA
|
0.097x |
|
Bien Sparebank ASA
OL:BIEN
|
-0.201x |
|
SKM Egg Products Export (India) Limited
NSE:SKMEGGPROD
|
-0.028x |
|
TMT Steel Public Company Limited
BK:TMT
|
0.022x |
|
MCOT Public Company Limited
F:OLU1
|
0.043x |
|
Carnaby Resources Ltd
AU:CNB
|
-0.074x |
|
Super Energy Corporation Public Company Limited
BK:SUPER
|
0.039x |
|
Bon Fame Co Ltd
TWO:8433
|
0.021x |
Annual Cash Flow Conversion Efficiency for Solesence, Inc. Common Stock (2021–2024)
The table below shows the annual cash flow conversion efficiency of Solesence, Inc. Common Stock from 2021 to 2024. For the full company profile with market capitalisation and key ratios, see SLSN company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $14.95 Million | $1.97 Million | 0.132x | +112.50% |
| 2023-12-31 | $1.90 Million | $-2.01 Million | -1.055x | -261.08% |
| 2022-12-31 | $5.65 Million | $-1.65 Million | -0.292x | -193.94% |
| 2021-12-31 | $7.46 Million | $2.32 Million | 0.311x | -- |
About Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin heal… Read more